Since Novo Nordisk was founded more than 90 years ago, we have been changing diabetes. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic diseases: haemophilia, growth disorders and obesity. Our ambition is to take the lead in each of these areas, driving change with an unfailing belief that it can be done.
Our key contribution is to discover, develop and deliver better biological medicines. With a strong focus on innovation and decades of experience in researching, developing and manufacturing proteins, we explore new research areas and continuously turn science and technologies into the next generation of efficacious and safe biological medicines. Alongside this, we design and develop innovative delivery devices based on patient insights.
Producing life-saving medicine is a significant responsibility: millions of people depend on us. That is why we combine our scientific expertise and deep disease understanding with insights into what it is like to live with a serious chronic condition. Only by considering what is valuable from a patient perspective can we help people live a life with as few limitations as possible.